Newport Medical Instruments Inc. has been acquired by Covidien plc
Newport Medical Instruments, Inc. (Newport), a manufacturer of ventilators for the portable, home care and critical care markets, has been acquired by Covidien plc. for US$108 million.
Newport is a physician-led company, focused on the design and manufacture of dependable ventilators that are affordable for caregivers worldwide.
Covidien plc. is a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices. Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.
Oaklins' team in Los Angeles was engaged by the shareholders of Newport to pursue a sale of the business.
Talk to the deal team
Adam Abramowitz
Oaklins Intrepid
Eduard Bagdasarian
Oaklins Intrepid
Steven Davis
Oaklins Intrepid
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more